Sentences with phrase «vaccine technology»

The DNA vaccine technology has not been easy to get to work in humans.

Today his company is developing a new cancer vaccine technology that teaches immune cells how to recognize and remove tumor cells.

This may be because of improved vaccine technology and using only portions of the organism rather than the entire bacterium.

The perspective concludes that modern vaccine technology and improved surveillance in developing countries ultimately can help us better prepare for emerging infectious disease threats.

In contrast to most older vaccine technologies, which use pathogens as a starting point for vaccine development, synthetic DNA vaccines are not developed from live pathogens.

There have been significant advances made in vaccine technology during the past 50 - plus years.

Recombinant vaccines represent the very cutting edge of vaccine technology in both veterinary and human medicine.

Moving the Needle provides quarterly updates from PATH's Center for Vaccine Innovation and Access (CVIA) on our vaccine development efforts, as well as related supporting work, such as developing human challenge models, building capacity of developing - country vaccine manufacturers, and evaluating new adjuvants and other novel vaccine technologies.

Recombinant vaccines represent the cutting edge of vaccine technology in both veterinary and human medicine.

Grant Title: 01787: Clinical advancement of RNA - transfected CD40 - B cell vaccine technology for cancer therapy

The Weiner Laboratory at Wistar is dedicated to accelerating DNA - based vaccine technology.

The nanoparticle vaccine technology used in the study has been licensed by Parvus Therapeutics, Inc., a biotechnology company arising from the University Technology International LP, the technology transfer and commercialization center for the University of Calgary.

A feline leukemia vaccine containing no complete virus and no adjuvants is Merial's Purevax products which uses recombinant canarypox vector vaccine technology.

RNA - transfected CD40 - B Cell Vaccines Study: Clinical Advancement of RNA - transfected CD40 - B Cell Vaccine Technology for Cancer Therapy Study Purpose: The purpose of this study is to determine whether repeat vaccinations with a cancer vaccine, made from your dog's own immune cells (B cells), can prevent relapse of lymphoma when given following a standard 19 - week course of -LSB-...]

BRUSSELS — CureVac, a company based in Tübingen, Germany, that develops RNA - based vaccines and therapies, has won a $ 2 million prize awarded by the European Commission to stimulate new vaccine technologies that might help the developing world.

«However, the promising results of this trial lay the foundations for the development of a more cost - effective, clinically - practical vaccine technology that could deliver similar outcomes for patients.

Other scientists add that it should force governments to rethink existing vaccine technologies, which are only capable of supplying vaccine six months after a pandemic starts, and of producing enough vaccine for a small fraction of the world population.

«Now I see how vaccine technology can be used against a host of public health issues.»

Amara is a co-inventor of vaccine technology described in the paper, and Emory has licensed the technology to Geovax.

«It's a powerful vaccine technology that efficiently delivers vaccine components to the right cells in the right tissues.

In April 2017, Moderna published human data for its mRNA vaccine technology in Molecular Therapy, which showed that its first prophylactic vaccine candidate, mRNA - 1440 — an mRNA prophylactic vaccine against avian H10N8 influenza — induced high levels of immunogenicity and was safe and well tolerated.

«This is a straightforward study of the use of two established vaccine technologies in an attempt to design and test new Zika vaccines.

The DNA vaccine type tested is known to be a poor means of inducing antibodies in humans, and difficult to scale up to very large quantities, so better vaccine technologies are likely to be needed.

He was responsible for or contributed to a number of vaccine - related EU guidelines and remains a consultant to WHO on influenza vaccine technology transfer to developing countries.

Phillips and Schultz, of the Scripps Research Institute and University of Wisconsin, respectively, reviewed the state of canine and feline vaccine technology in Current Veterinary Therapy XI.

Novel vaccine technologies are critical to improving the public health response to infectious disease threats that continually emerge and re-emerge, according to scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

«But, overall, this report illustrates well the current rapid pace of Zika vaccine development and one US company (Inovio) reported recently plans to start a trial of their DNA vaccine technology for Zika very soon.»

Specifically, the lab of David Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center at The Wistar Institute, and the W.W. Smith Charitable Trust Professor in Cancer Research, is using their novel DNA - based vaccine technology to specifically target cancers caused by HPV - 16 and HPV - 18, the two strains of the virus that are most likely to progress to cancer.

As an added benefit, PUREVAX Recombinant Leukemia vaccine employs canarypox - vectored vaccine technology.

This may be because of improved vaccine technology.

5) Explore new vaccine technologies — Longer term, we need to evaluate new ways to vaccinate wild carnivores for distemper, in situations wherein use of an injectable vaccine is not feasible by hand or by dart.

A recent synergy has made these new oral vaccine efforts possible: improvements in vaccine technology (developed for humans and domesticated animals) and growing public and scientific interest in «One Health.»

Synthetic DNA vaccine technology has many advantages over older technologies for vaccine production.

The vaccine technology clearly has a biological effect that prevents dengue,» says Derek Wallace, regional director of clinical development for Sanofi Pasteur, the French pharmaceutical firm developing the vaccine, who reported results online today at The Lancet.

The engineer has designed air - purifying plants, edible bottles and vaccine technologies to deliver drugs to the lungs to eliminate injections, among other inventions.

Those selected for funding range from an antibacterial coating for orthopedic implants to a novel nano - vaccine technology to a potential next - generation cancer therapeutic.

Because the H10N8 and H7N9 strains are not circulating in the general population where the trials are taking place (the U.S. and Germany), Moderna is able to study the efficacy of its vaccine technology in naïve patient populations.

Novel vaccine technologies are critical to improving the public health response to infectious disease threats that continually emerge and re-emerge, according to scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part...

In the last few years, advances in both vaccine technology and our understanding of the workings of the immune system have lead to a new three - year protocol for some vaccines, such as distemper and parvo.

This is a new treatment that uses vaccine technology to eliminate one of the main mediators of itch sensation.

We can get ahead of it with proper annual screening, vaccination with advanced vaccine technology, and effective tick prevention.

QUALIFICATIONS Clinical Molecular Biology Microbiology, Vaccine Technology, CAP & JCAHO inspector, CLIA, Hospital Infection Control, Quality Control ISO 9000, LEAN, RNA, DNA, PCR Assay, Manager for Clinical Laboratory and Cytology / Histology Project manager for first bi-direction interface in the world between laboratory computer (CHC) and Microbiology instrument.